Quick Takeaways
- This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 2 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 06 Apr 2022, 18:35.
Michael Egholm - 04 Apr 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)
- Signature
- /s/ Michael Egholm by Nicholas Khadder, Attorney-in-Fact
- Issuer symbol
- LAB
- Transactions as of
- 04 Apr 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 06 Apr 2022, 18:35:59 UTC
- Previous filing
- 07 Oct 2021
- Next filing
- 21 Jun 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 06 Apr 2022."
What Changed
- Previous filing in this sequence was filed on 07 Oct 2021.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Restricted Stock Units | Award | $0 | +786,049 | $0.000000 | 786,049 | 04 Apr 2022 | Common Stock | 786,049 | Direct | F1, F2 | ||
| transaction | LAB | Stock Option (Right to Buy) | Award | $0 | +4,529,773 | $0.000000 | 4,529,773 | 04 Apr 2022 | Common Stock | 4,529,773 | $3.99 | Direct | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. |
| F2 | Restricted Stock Units vest in four equal annual installments beginning April 4, 2023. |
| F3 | The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter. |